Abstract: A tissue box comprising front and rear surfaces including horizontal fold lines; a left end surface including a horizontal fold line and a vertical perforation line; a right end surface including a horizontal fold line and a vertical perforation line; a top surface including a tissue pull-out-port; a bottom surface including a horizontal perforation line at the center of said bottom surface and vertical perforation lines at either end; lock keys form in said bottom surface so that said left end surface and right end surface can tuck in said lock keys; and said front surface, rear surface, left end surface, right end surface, top surface, and bottom surface all foldably connect to form a rectangular box. By its construction, said tissue box height can be reduced to prevent the termination of the cascade pulling mechanism when the remaining number of tissues in the box becomes half or less.

Abstract: A tissue box comprising front and rear surfaces including horizontal fold lines; a left end surface including a horizontal fold line and a vertical perforation line; a right end surface including a horizontal fold line and a vertical perforation line; a top surface including a tissue pull-out-port; a bottom surface including a horizontal perforation line at the center of said bottom surface and vertical perforation lines at either end; lock keys form in said bottom surface so that said left end surface and right end surface can tuck in said lock keys; and said front surface, rear surface, left end surface, right end surface, top surface, and bottom surface all foldably connect to form a rectangular box. By its construction, said tissue box height can be reduced to prevent the termination of the cascade pulling mechanism when the remaining number of tissues in the box becomes half or less.

Abstract: An operation method of a first access point (AP) may comprise: transmitting, to a control device of a base station, channel information between the first AP and one or more user equipments (UEs) connected to the base station; receiving allocation information determined by the control device; identifying an entity to decode a uplink (UL) signal of each of the one or more UEs from among a plurality of APs and the control device constituting the base station, based on the allocation information; directly performing a decoding operation on a first UL signal received from a first UE among the one or more UEs, based on the allocation information; and transmitting, to the control device, a first report related to a result of the decoding operation on the first UL signal.

Abstract: The present invention relates to a 3-phenyl-2H-chromene derivative and a pharmaceutical composition for preventing or treating Alzheimer’s, containing same as an active ingredient. The compound, a solvate thereof, a hydrate thereof, or a pharmaceutically acceptable salt thereof, provided according to one aspect of the present invention, inhibits, with high activity, the fibrosis and oligomerization of A? and thus has the effect of being usefully employable for preventing or treating Alzheimer’s.

Abstract: Provided herein is a pipette tip for electroporation including an outer surface, a void located within the outer surface, and a conductor located at least partially on or within the outer surface, in electrical communication with at least a portion of the outer surface and the void. Further provided herein is a pipette tip for electroporation including a body, a connector, and an elongated part. The connector is located at the distal end of the body and further includes at least one connecting post, a connecting part in mechanical communication with the connector, and a conductor located at least partially on or within the connector, wherein the conductor surrounds at least a portion of the connecting post. The elongated part also has a void and is located at the distal end of the connector. The void of the body, connector, and elongated part are in fluid communication.

Abstract: A drug delivery device includes a housing, a drug delivery assembly disposed within the housing along a longitudinal axis, and a cap defining a shell. At least one electronic component, a power source, and a switch assembly are at least partially disposed in and coupled to the cap. The switch assembly is movable along a plane orthogonal to the longitudinal axis of the drug delivery assembly to cause the power source to provide power to the electronic component. The device further includes an activation mechanism at least partially disposed in the cap. Upon urging the cap along the longitudinal axis in a direction away from the housing, the activation mechanism engages the switch assembly and causes the switch assembly to move, thereby causing the power source to provide power to the at least one electronic component.

Abstract: The present invention relates to a system and a method of determining disease based on a heat map image explainable from an electrocardiogram signal, which determine an electrocardiogram signal as a normal signal and a disease signal by transfer-learning a transfer-learning model through a deep learning network, calculate and visualize a part with a high relevance score to the determination to enable a user to objectively and finally determine the disease and the normal state.

Abstract: An electroporation apparatus comprising an elongated hollow member in order to provide a uniform electric field during electroporation, wherein specifically, electroporation is carried out by applying electric pulses through a couple of electrodes from both end parts of the elongated hollow member, after the hollow member is charged with fluid specimen including cells and material which would be injected into the cells.

Abstract: An electroporation apparatus comprising an elongated hollow member in order to provide a uniform electric field during electroporation, wherein specifically, electroporation is carried out by applying electric pulses through a couple of electrodes from both end parts of the elongated hollow member, after the hollow member is charged with fluid specimen including cells and material which would be injected into the cells.

Abstract: The present invention relates to a composition for screening ongoing progress of Alzheimer's disease using beta amyloid of a nose discharge sample and a method of screening ongoing progress of Alzheimer's disease using the same, more specifically, to a composition and a kit for screening ongoing progress of Alzheimer's disease, comprising an agent measuring an expression level of a 56 kDa beta amyloid oligomer and a 72 kDa beta amyloid oligomer in an nose discharge sample, and a method of screening ongoing progress of Alzheimer's disease comprising measuring the expression level of the 56 kDa and 72 kDa beta amyloid oligomers in an nose discharge sample.

Abstract: The present invention relates to a hydrocracking catalyst based on hierarchically porous beta-zeolite, a method of preparing the same, and a method of producing bio-jet fuel from triglyceride-containing biomass by use of the hydrocracking catalyst, and includes methods comprising preparing a hydrocracking catalyst by supporting a metallic active component on a hierarchically porous beta-zeolite support, and converting n-paraffins, produced from triglyceride-containing biomass, into bio-jet fuel by hydrocracking in the presence of the prepared hydrocracking catalyst. When the hydrocracking catalyst based on hierarchically porous beta-zeolite is used, the residence time of the reactant and the product in the zeolite crystals may be reduced due to additional mesopores formed in the zeolite, and thus bio-jet fuel may be produced in high yield from n-paraffin feedstock produced from triglyceride-containing biomass.

Abstract: The present invention relates to an SMB-based fucose separation method and an apparatus therefor and, more particularly, to a method and an apparatus for continuously separating fucose from a microalgae-derived monosaccharide mixture or a multi-component mixture (monosaccharide substances, amino acid substances, and glycerol components) using an SMB process.

Abstract: A drug delivery device includes a housing, a drug delivery assembly disposed within the housing along a longitudinal axis, and a cap defining a shell. At least one electronic component, a power source, and a switch assembly are at least partially disposed in and coupled to the cap. The switch assembly is movable along a plane orthogonal to the longitudinal axis of the drug delivery assembly to cause the power source to provide power to the electronic component. The device further includes an activation mechanism at least partially disposed in the cap. Upon urging the cap along the longitudinal axis in a direction away from the housing, the activation mechanism engages the switch assembly and causes the switch assembly to move, thereby causing the power source to provide power to the at least one electronic component.

Abstract: Provided herein is a pipette tip for electroporation including an outer surface, a void located within the outer surface, and a conductor located at least partially on or within the outer surface, in electrical communication with at least a portion of the outer surface and the void. Further provided herein is a pipette tip for electroporation including a body, a connector, and an elongated part. The connector is located at the distal end of the body and further includes at least one connecting post, a connecting part in mechanical communication with the connector, and a conductor located at least partially on or within the connector, wherein the conductor surrounds at least a portion of the connecting post. The elongated part also has a void and is located at the distal end of the connector. The void of the body, connector, and elongated part are in fluid communication.

Abstract: Disclosed are a method for generating personal identification information using an electrocardiogram and a method for identifying a person using the personal identification information. The methods dramatically increase an identification rate by using two-dimensional image data converted from an electrocardiogram signal as personal identification information, and enable real-time identification by reducing a calculation amount by converting only a single electrocardiogram cycle into the two-dimensional image data.

Abstract: Provided herein is a pipette tip for electroporation including an outer surface, a void located within the outer surface, and a conductor located at least partially on or within the outer surface, in electrical communication with at least a portion of the outer surface and the void. Further provided herein is a pipette tip for electroporation including a body, a connector, and an elongated part. The connector is located at the distal end of the body and further includes at least one connecting post, a connecting part in mechanical communication with the connector, and a conductor located at least partially on or within the connector, wherein the conductor surrounds at least a portion of the connecting post. The elongated part also has a void and is located at the distal end of the connector. The void of the body, connector, and elongated part are in fluid communication.

Abstract: An apparatus for clearing tissue using electrophoresis according to an embodiment of the present invention comprises: a chamber which can contain therein a buffer solution and the biological tissue and has an inlet port and an outlet port for circulating the buffer solution; a support member, located within the chamber, for supporting the biological tissue; and electrodes located within the chamber and formed separately of a first electrode and a second electrode which correspond to each other. With the apparatus, it is possible to minimize the degradation of decomposition efficiency and quickly clear the tissue compared to a conventional apparatus.

Abstract: The present invention relates to a hydrocracking catalyst based on hierarchically porous beta-zeolite, a method of preparing the same, and a method of producing bio-jet fuel from triglyceride-containing biomass by use of the hydrocracking catalyst, and includes methods comprising preparing a hydrocracking catalyst by supporting a metallic active component on a hierarchically porous beta-zeolite support, and converting n-paraffins, produced from triglyceride-containing biomass, into bio-jet fuel by hydrocracking in the presence of the prepared hydrocracking catalyst. When the hydrocracking catalyst based on hierarchically porous beta-zeolite is used, the residence time of the reactant and the product in the zeolite crystals may be reduced due to additional mesopores formed in the zeolite, and thus bio-jet fuel may be produced in high yield from n-paraffin feedstock produced from triglyceride-containing biomass.

Abstract: An electroporation apparatus comprising an elongated hollow member in order to provide a uniform electric field during electroporation, wherein specifically, electroporation is carried out by applying electric pulses through a couple of electrodes from both end parts of the elongated hollow member, after the hollow member is charged with fluid specimen including cells and material which would be injected into the cells.

Abstract: Disclosed are a method for generating personal identification information using an electrocardiogram and a method for identifying a person using the personal identification information. The methods dramatically increase an identification rate by using two-dimensional image data converted from an electrocardiogram signal as personal identification information, and enable real-time identification by reducing a calculation amount by converting only a single electrocardiogram cycle into the two-dimensional image data.